World's Best Scientists 2026 revealed!
Chiara Castelli

Chiara Castelli

D-Index & Metrics

Immunology

D-Index
56
Citations
17926
World Ranking
3671
National Ranking
151

Chiara Castelli publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Chiara Castelli sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 163 publications — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Chiara Castelli D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Chiara Castelli sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 56 D-Index — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Chiara Castelli is affiliated with the University of Milan in Italy and has contributed extensively to the field of medicine, focusing on oncology and immunology among other subfields. Their research output includes 36 publications primarily related to medicine, with significant emphasis in oncology, immunology, pulmonary and respiratory medicine, cancer research, and rheumatology.

The scientist's recent works cover key areas such as cancer immunotherapy, immune cell functions, extracellular vesicles, and microRNA regulation. Specific main topics of research addressed by Chiara Castelli include:

  • Cancer Immunotherapy and Biomarkers
  • Immune cells in cancer
  • Sarcoma Diagnosis and Treatment
  • Extracellular vesicles in disease
  • MicroRNA in disease regulation
  • Immune Cell Function and Interaction
  • Ferroptosis and cancer prognosis

Chiara Castelli has published several papers recently, including:

  • Extracellular vesicles in anti-tumor immunity, 2021, Seminars in Cancer Biology
  • The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis, 2021, Cells
  • Molecular Determinants of Soft Tissue Sarcoma Immunity: Targets for Immune Intervention, 2021, International Journal of Molecular Sciences
  • Y90-radioembolisation in hepatocellular carcinoma induces immune responses calling for early treatment with multiple checkpoint blockers, 2022, Gut
  • microRNAs Shape Myeloid Cell-Mediated Resistance to Cancer Immunotherapy, 2020, Frontiers in Immunology

The frequent co-authors collaborating with Chiara Castelli include Licia Rivoltini, Viviana Vallacchi, Laura Bergamaschi, Luca Lalli, and Monica Rodolfo. These collaborations have been reflected in multiple joint publications, indicating ongoing research partnerships.

Their research has been published across several notable scientific venues. The publications are often found in:

  • Annals of Oncology
  • Seminars in Cancer Biology
  • Cells
  • International Journal of Molecular Sciences
  • Gut

Best Publications

  • Phenotypic characterization of human colorectal cancer stem cells

    Piero Dalerba;Scott J. Dylla;In Kyung Park;Rui Liu

  • A listing of human tumor antigens recognized by T cells.

    Nicolina Renkvist;Chiara Castelli;Paul F. Robbins;Giorgio Parmiani

  • Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor Vaccine

    Paola Filipazzi;Roberta Valenti;Veronica Huber;Lorenzo Pilla

  • Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles.

    Giovanna Andreola;Licia Rivoltini;Chiara Castelli;Veronica Huber

  • A listing of human tumor antigens recognized by T cells: March 2004 update

    Luisa Novellino;Chiara Castelli;Giorgio Parmiani

  • Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation

    Veronica Huber;Chiara Camisaschi;Angela Berzi;Simona Ferro

  • Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease.

    Francesca Romana Ponziani;Sherrie Bhoori;Chiara Castelli;Lorenza Putignani

  • Classification of current anticancer immunotherapies

    Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué

  • Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?

    Giorgio Parmiani;Chiara Castelli;Piero Dalerba;Roberta Mortarini

  • Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients

    Giorgio Parmiani;C. Castelli;L. Pilla;M. Santinami

  • LAG-3 expression defines a subset of CD4(+)CD25(high)Foxp3(+) regulatory T cells that are expanded at tumor sites.

    Chiara Camisaschi;Chiara Casati;Francesca Rini;Michela Perego

  • Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen.

    Markus J. Maeurer;Susanne M. Gollin;Dina Martin;William Swaney

  • Immunity to cancer: attack and escape in T lymphocyte–tumor cell interaction

    Licia Rivoltini;Matteo Carrabba;Veronica Huber;Chiara Castelli

  • Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes.

    Chiara Castelli;Walter J. Storkus;Markus J. Maeurer;Dina M. Martin

  • Modulation of Pulmonary Microbiota by Antibiotic or Probiotic Aerosol Therapy: A Strategy to Promote Immunosurveillance against Lung Metastases

    Valentino Le Noci;Simone Guglielmetti;Stefania Arioli;Chiara Camisaschi

  • Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells.

    Chiara Castelli;Anne-Marie T. Ciupitu;Francesca Rini;Licia Rivoltini

  • Unique human tumor antigens : Immunobiology and use in clinical trials

    Giorgio Parmiani;Annamaria De Filippo;Luisa Novellino;Chiara Castelli

  • Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1((27-35))

    Douglas J. Loftus;Chiara Castelli;Timothy M. Clay;Paola Squarcina

  • Immunology and immunotherapy of colorectal cancer.

    Piero Dalerba;Cristina Maccalli;Chiara Casati;Chiara Castelli

  • T-cell recognition of melanoma-associated antigens.

    Chiara Castelli;Licia Rivoltini;Giovanna Andreola;Matteo Carrabba

  • Identification of Epitope Mimics Recognized by CTL Reactive to the Melanoma/Melanocyte-derived Peptide

    Douglas J. Loftus;Chiara Castelli;Timothy M. Clayfi;Paola Squarcina

Frequent Co-Authors

Licia Rivoltini
Licia Rivoltini Fondazione IRCCS Istituto Nazionale dei Tumori
Giorgio Parmiani
Giorgio Parmiani University of Siena
Markus Maeurer
Markus Maeurer Champalimaud Foundation
Andrea Anichini
Andrea Anichini Fondazione IRCCS Istituto Nazionale dei Tumori
Antonello Villa
Antonello Villa University of Milano-Bicocca
Silvia Stacchiotti
Silvia Stacchiotti University of Milan
Silvana Pilotti
Silvana Pilotti University of Milan
Michael T. Lotze
Michael T. Lotze University of Pittsburgh
Vincenzo Mazzaferro
Vincenzo Mazzaferro University of Milan
Paolo G. Casali
Paolo G. Casali University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond Immunology, exploring related healthcare degrees can open up diverse career opportunities. Programs such as accelerated NP programs offer a fast-tracked route to becoming a Nurse Practitioner, blending advanced clinical skills with immunological knowledge.

Individuals without a nursing background might consider 12-month accelerated nursing programs online for non nurses, which are designed to transition non-nurses into competent healthcare professionals quickly and effectively. These programs can complement immunology expertise by enhancing patient care capabilities.

For those seeking the quickest pathway to nursing licensure, 12-month accelerated nursing programs provide streamlined options. These intensive courses offer a balance of speed and quality, critical for timely entry into healthcare roles connected with immunology research or practice.

Additionally, the best easiest LPN programs to get into are ideal for those seeking practical nursing credentials with flexible admissions. Such programs can serve as stepping stones toward more advanced immunology-related healthcare careers.

Best Scientists Citing Chiara Castelli

Trending Scientists

Recently Published Articles